Characteristic peripheral blood findings in human ehrlichiosis.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002460:Cell Line; D004269:DNA, Bacterial / Q000235:genetics; D004318:Doxycycline / Q000627:therapeutic use; D004536:Ehrlichia / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D018469:Ehrlichia chaffeensis / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification*; D016873:Ehrlichiosis / Q000097:blood* / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D006098:Granulocytes / Q000187:drug effects / Q000382:microbiology; D006801:Humans; D016867:Immunocompromised Host; D008214:Lymphocytes / Q000187:drug effects / Q000382:microbiology; D008297:Male; D009000:Monocytes / Q000187:drug effects / Q000382:microbiology; D016133:Polymerase Chain Reaction; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D012336:RNA, Ribosomal, 16S; D004318:Doxycycline